Shay Shemesh
Patrimonio netto: 17 M $ in data 31/05/2026
Patrimonio netto: 17 M $ in data 31/05/2026
Shay Shemesh is the founder of Nuvectis Pharma, Inc., founded in 2020, holding the title Chief Development & Operations Officer, EVP.
Former jobs include Head-Clinical Operations at Keryx Biopharmaceuticals, Inc. and Senior VP-Clinical & Regulatory Affairs at Stemline Therapeutics, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Bar-Ilan University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/04/2026 | 1.793.068 ( 6,76% ) | 17 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NUVECTIS PHARMA, INC. | Fondatore | 27/07/2020 |
| Società | Posizione | Fine |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
| KERYX BIOPHARMACEUTICALS | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale